Press Release Articles (2025)

• Academic Conference Presentation on the Results of Phase 1 Clinical Study in Europe on a Novel Universal Influenza Vaccine Candidate Formulated with Sumitomo Pharma’s Proprietary TLR7 Adjuvant (DSP-0546)2025年10月1日
• Announce the publication of a comprehensive Adjuvant Database to facilitate preclinical evaluation of vaccines and immunotherapeutics2025年8月11日
• Interim Analysis of Phase 1 Clinical Study on Novel Universal Influenza Vaccine Candidate Formulated with Sumitomo Pharma’s Proprietary TLR7 Adjuvant (DSP-0546)2025年7月31日
• The Logo and Abbreviation will be changed for the 10th Anniversary from April!2025年1月17日